| 1 | 2Y56 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1S,5R)-8-[(2R)-2-HYDROXY-2-PHENYL-ETHYL]-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V11 |
 |
SHOW |
| 2 | 6XEC |
Histone deacetylase 2 | Homo sapiens |
Q92769 (HDAC2_HUMAN) |
(1S)-N-{(1S)-1-[5-cyano-2-(4-fluorophenyl)-1H-imidazol-4-yl]-7,7-dihydroxynonyl}-6-methyl-6-azaspiro[2.5]octane-1-carboxamide |
V1S |
 |
SHOW |
| 3 | 2Y57 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1R,5S)-8-PHENETHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V37 |
 |
SHOW |
| 4 | 5R5O |
Uridine diphosphate glucose pyrophosphatase NUDT22 | Homo sapiens |
Q9BRQ3 (NUD22_HUMAN) |
(4,7-dihydro-2H-1lambda~4~,2,3-benzothiadiazol-5-yl)(morpholin-4-yl)methanone |
V3J |
 |
SHOW |
| 5 | 6IMZ |
7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens |
P36639 (8ODP_HUMAN) |
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine |
VGH |
 |
SHOW |
| 6 | 4KYS |
Thiamine pyridinylase I | Clostridium botulinum A str. ATCC 19397 |
- |
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM |
VIB |
 |
SHOW |
| 7 | 7JV8 |
5'-nucleotidase | Homo sapiens |
P21589 (5NTD_HUMAN) |
6-chloro-N-cyclopentyl-1-{5-O-[(2R)-1-hydroxy-3-methoxy-2-phosphonopropan-2-yl]-beta-D-ribofuranosyl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
VPD |
 |
SHOW |
| 8 | 7JV9 |
5'-nucleotidase | Homo sapiens |
P21589 (5NTD_HUMAN) |
6-chloro-N-[(2-chlorophenyl)methyl]-1-[5-O-(phosphonomethyl)-beta-D-ribofuranosyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
VPG |
 |
SHOW |
| 9 | 2XNU |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
 |
SHOW |
| 10 | 2XNV |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
|
SHOW |